01 2AbbVie Corporation
02 3Gowling WLG (Canada) LLP
01 12379605
02 12414680
03 12429998
04 12459930
05 12512315
01 2Ciprofloxacin | Dexamethasone
02 3Dexamethasone
01 3Intravitreal injection
02 2Suspension
01 12020-08-10
02 12021-07-03
03 12021-11-28
04 12022-09-13
05 12024-01-07
Patent Expiration Date : 2021-11-28
Date Granted : 2012-01-17
Brand Name : OZURDEX
Patent Number : 2429998
Filing Date : 2001-11-28
Strength per Unit : 0.7 mg
Dosage Form : Intravitreal injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2021-11-28
Date Granted : 2012-01-17
Patent Expiration Date : 2021-07-03
Date Granted : 2007-09-18
Brand Name : OZURDEX
Patent Number : 2414680
Filing Date : 2001-07-03
Strength per Unit : 0.7 mg
Dosage Form : Intravitreal injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2021-07-03
Date Granted : 2007-09-18
Patent Expiration Date : 2024-01-07
Date Granted : 2008-12-30
Brand Name : OZURDEX
Patent Number : 2512315
Filing Date : 2004-01-07
Strength per Unit : 0.7 mg
Dosage Form : Intravitreal injection
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2024-01-07
Date Granted : 2008-12-30
Patent Expiration Date : 2022-09-13
Date Granted : 2009-11-10
Brand Name : CIPRODEX
Patent Number : 2459930
Filing Date : 2002-09-13
Strength per Unit : 0.3% (w / v) / 0.1% (w / v)
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Otic
Patent Expiration Date : 2022-09-13
Date Granted : 2009-11-10
Patent Expiration Date : 2020-08-10
Date Granted : 2007-06-26
Brand Name : CIPRODEX
Patent Number : 2379605
Filing Date : 2000-08-10
Strength per Unit : 0.3% (w / v) / 0.1% (w / v)
Dosage Form : Suspension
Human Or VET : Human
Route of Administration : Otic
Patent Expiration Date : 2020-08-10
Date Granted : 2007-06-26
